These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34534173)

  • 21. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K;
    Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction.
    Gupta G; Regmi A; Kumar D; Posner S; Posner MP; Sharma A; Cotterell A; Bhati CS; Kimball P; Massey HD; King AL
    Am J Transplant; 2015 Oct; 15(10):2726-31. PubMed ID: 25988397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy and the kidney transplant recipient.
    Vijayan M; Pavlakis M
    Curr Opin Nephrol Hypertens; 2017 Nov; 26(6):494-500. PubMed ID: 28985190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
    Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
    J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports.
    Gouvêa ALF; Cosendey RIJ; Nascimento ALR; Carvalho FR; Silva AA; de Moraes HP; Rochael MC; Varella RB; Almeida SG; Almeida JR; Lugon JR
    J Med Case Rep; 2017 May; 11(1):146. PubMed ID: 28535782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
    Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
    Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.
    Zaza G; Dalla Gassa A; Felis G; Granata S; Torriani S; Lupo A
    PLoS One; 2017; 12(5):e0178228. PubMed ID: 28542523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities.
    Tornatore KM; Attwood K; Venuto RC; Murray B
    Clin Transl Sci; 2023 May; 16(5):861-871. PubMed ID: 36840340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal, Decidual, and Neonatal Lymphocyte Composition Is Affected in Pregnant Kidney Transplant Recipients.
    Feyaerts D; Gillard J; van Cranenbroek B; Rigodanzo Marins L; Baghdady MMS; Comitini G; Lely AT; van Hamersvelt HW; van der Heijden OWH; Joosten I; van der Molen RG
    Front Immunol; 2021; 12():735564. PubMed ID: 34777345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.
    Gelens MA; Steegh FM; van Hooff JP; van Suylen RJ; Nieman FH; van Heurn LW; Peutz-Kootstra CJ; Christiaans MH
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):1010-7. PubMed ID: 22490875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
    Höcker B; Tönshoff B
    Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
    Morissette P; Albert C; Busque S; St-Louis G; Vinet B
    Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice.
    Zhang Z; Liu L; Tang H; Jiao W; Zeng S; Xu Y; Zhang Q; Sun Z; Mukherjee A; Zhang X; Hu X
    Am J Transplant; 2018 Jul; 18(7):1646-1656. PubMed ID: 29316256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
    Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
    Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice.
    Cucchiari D; Molina-Andujar A; Montagud-Marrahi E; Revuelta I; Rovira J; Ventura-Aguiar P; Piñeiro GJ; De Sousa-Amorim E; Esforzado N; Cofán F; Torregrosa JV; Ugalde-Altamirano J; Ricart MJ; Centellas-Pérez FJ; Solè M; Martorell J; Ríos J; Campistol JM; Diekmann F; Oppenheimer F
    Transplantation; 2020 Aug; 104(8):1686-1694. PubMed ID: 32732848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients.
    Griffin SP; Nelson JE
    Prog Transplant; 2016 Dec; 26(4):314-321. PubMed ID: 27628498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.
    Belliere J; Kamar N; Mengelle C; Allal A; Sallusto F; Doumerc N; Game X; Congy-Jolivet N; Esposito L; Debiol B; Rostaing L
    Transpl Int; 2016 Mar; 29(3):315-22. PubMed ID: 26575959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients.
    Meaney CJ; Arabi Z; Venuto RC; Consiglio JD; Wilding GE; Tornatore KM
    BMC Nephrol; 2014 Jun; 15():88. PubMed ID: 24925208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients.
    Wu JF; Muthusamy A; Al-Ghalith GA; Knights D; Guo B; Wu B; Remmel RP; Schladt DP; Alegre ML; Oetting WS; Jacobson PA; Israni AK
    Clin Transplant; 2018 Dec; 32(12):e13436. PubMed ID: 30372560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.